Why is Biocon falling/rising?

As of 29-Jul, Biocon Ltd. is experiencing a price increase, currently at 398.30, reflecting a change of 10.9 or 2.81% upward. The stock has shown a positive trend, gaining 2.91% over the past week and 12.48% over the past month, while outperforming its sector by 1.4% today. It is also close to its 52-week high, just 1.91% away from Rs 405.9. Key positive factors contributing to this rise include a high inventory turnover ratio and strong operating profit relative to interest, alongside a significant growth in profit after tax. Additionally, the stock is trading at a discount compared to its peers, and institutional holdings have increased, indicating confidence from larger investors. However, concerns about the company's ability to service debt due to a high Debt to EBITDA ratio and low long-term growth potential remain. In the broader market context, Biocon's recent performance contrasts sharply with the benchmark, as the BSE500 has generated negative returns of -2.26% over the past year, while Biocon has achieved a return of 10.10%. This divergence highlights the stock's resilience and market-beating performance despite broader market challenges. The stock's ability to maintain a positive trajectory amidst a declining market suggests strong underlying fundamentals and investor confidence, further supported by rising investor participation and favorable liquidity conditions.